Current issues in the management of actinic keratosis
- PMID: 23228304
- DOI: 10.1016/j.jaad.2012.09.051
Current issues in the management of actinic keratosis
Abstract
Actinic keratoses are common sun-induced skin lesions that should be treated to prevent the development of nonmelanoma skin cancer. Although cryotherapy is commonly used to treat individual lesions, it fails to address the actinically damaged field of neighboring sun-damaged skin, which is more effectively treated by field therapies to clear both visible and subclinical lesions. Most topical treatments require prolonged use and cause an inflammatory response that limits tolerability and adherence. Education is essential to teach patients about the chronic nature of actinic keratosis, the risk of nonmelanoma skin cancer, and the importance of correct use of topical medications. The addition of nonphysician clinicians to dermatologic practices provides a valuable source of education, treatment, and follow-up care to the management of actinic keratosis.
Copyright © 2012 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.
Similar articles
-
Topical management of actinic keratosis and field cancerisation.G Ital Dermatol Venereol. 2009 Aug;144(4):459-62. G Ital Dermatol Venereol. 2009. PMID: 19755950
-
Optimizing management of actinic keratosis and photodamaged skin: utilizing a stepwise approach.Cutis. 2009 Sep;84(3):169-75. Cutis. 2009. PMID: 19842577
-
The paradigm shift in treating actinic keratosis: a comprehensive strategy.J Drugs Dermatol. 2012 Dec;11(12):1462-7. J Drugs Dermatol. 2012. PMID: 23377517 Review.
-
[Diagnosis and treatment of actinic keratosis].Duodecim. 2015;131(9):863-70. Duodecim. 2015. PMID: 26237885 Review. Finnish.
-
Randomized, double-blind, double-dummy, vehicle-controlled study of ingenol mebutate gel 0.025% and 0.05% for actinic keratosis.J Am Acad Dermatol. 2009 Jun;60(6):934-43. doi: 10.1016/j.jaad.2009.01.008. J Am Acad Dermatol. 2009. PMID: 19467365 Clinical Trial.
Cited by
-
Skin cancer precursor immunotherapy for squamous cell carcinoma prevention.JCI Insight. 2019 Mar 21;4(6):e125476. doi: 10.1172/jci.insight.125476. eCollection 2019 Mar 21. JCI Insight. 2019. PMID: 30895944 Free PMC article. Clinical Trial.
-
Sequential treatment of multiple actinic keratoses with solaraze and actikerall.Case Rep Dermatol. 2014 Jul 2;6(2):164-8. doi: 10.1159/000365070. eCollection 2014 May. Case Rep Dermatol. 2014. PMID: 25120467 Free PMC article.
-
Pharmacokinetics and Safety of Ingenol Disoxate Gel Administered Under Maximum-Use Conditions to Patients With Actinic Keratosis.Clin Drug Investig. 2018 Mar;38(3):249-257. doi: 10.1007/s40261-017-0608-y. Clin Drug Investig. 2018. PMID: 29204958 Clinical Trial.
-
Review of Clinical Evidence over 10 Years on Prevention and Treatment of a Film-Forming Medical Device Containing Photolyase in the Management of Field Cancerization in Actinic Keratosis.Dermatol Ther (Heidelb). 2019 Jun;9(2):259-270. doi: 10.1007/s13555-019-0294-1. Epub 2019 Apr 9. Dermatol Ther (Heidelb). 2019. PMID: 30968311 Free PMC article. Review.
-
Relationship between actinic keratosis and malignant skin lesions on the eyelid.Arq Bras Oftalmol. 2023 Jan-Feb;86(1):1-6. doi: 10.5935/0004-2749.20230002. Arq Bras Oftalmol. 2023. PMID: 35170648 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources